Avalyn Pharma Inc. financial statements
Avalyn Pharma Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 85.2M | EODHD |
| Cash and equivalents | USD 52.31M | EODHD |
| Total debt | USD 1.67M | EODHD |
Avalyn Pharma Inc. financials on 6ix · Avalyn Pharma Inc. on 6ix